Your browser doesn't support javascript.
loading
Genomic epidemiology of SARS-CoV-2 in Russia reveals recurring cross-border transmission throughout 2020.
Matsvay, Alina; Klink, Galya V; Safina, Ksenia R; Nabieva, Elena; Garushyants, Sofya K; Biba, Dmitry; Bazykin, Georgii A; Mikhaylov, Ivan M; Say, Anna V; Zakamornaya, Anastasiya I; Khakhina, Anastasiya O; Lisitsa, Tatiana S; Ayginin, Andrey A; Abramov, Ivan S; Bogdan, Sergey A; Kolbutova, Kseniya B; Oleynikova, Daria U; Avdeenko, Tatiana F; Shipulin, German A; Yudin, Sergey M; Skvortsova, Veronika I.
Afiliación
  • Matsvay A; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Klink GV; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
  • Safina KR; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
  • Nabieva E; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
  • Garushyants SK; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
  • Biba D; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
  • Bazykin GA; A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
  • Mikhaylov IM; Skolkovo Institute of Science and Technology (Skoltech), Moscow, Russia.
  • Say AV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Zakamornaya AI; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Khakhina AO; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Lisitsa TS; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Ayginin AA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Abramov IS; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Bogdan SA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Kolbutova KB; Chief Federal State Budgetary Healthcare Institution "Centre of Hygiene and Epidemiology" of the Federal Medical Biological Agency, Moscow, Russia.
  • Oleynikova DU; Chief Federal State Budgetary Healthcare Institution "Centre of Hygiene and Epidemiology" of the Federal Medical Biological Agency, Moscow, Russia.
  • Avdeenko TF; Chief Federal State Budgetary Healthcare Institution "Centre of Hygiene and Epidemiology" of the Federal Medical Biological Agency, Moscow, Russia.
  • Shipulin GA; Chief Federal State Budgetary Healthcare Institution "Centre of Hygiene and Epidemiology" of the Federal Medical Biological Agency, Moscow, Russia.
  • Yudin SM; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
  • Skvortsova VI; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, Moscow, Russia.
PLoS One ; 18(5): e0285664, 2023.
Article en En | MEDLINE | ID: mdl-37192187
ABSTRACT
In 2020, SARS-CoV-2 has spread rapidly across the globe, with most nations failing to prevent or substantially delay its introduction. While many countries have imposed some limitations on trans-border passenger traffic, the effect of these measures on the global spread of COVID-19 strains remains unclear. Here, we report an analysis of 3206 whole-genome sequences of SARS-CoV-2 samples from 78 regions of Russia covering the period before the spread of variants of concern (between March and November 2020). We describe recurring imports of multiple COVID-19 strains into Russia throughout this period, giving rise to 457 uniquely Russian transmission lineages, as well as repeated cross-border transmissions of local circulating variants out of Russia. While the phylogenetically inferred rate of cross-border transmissions was somewhat reduced during the period of the most stringent border closure, it still remained high, with multiple inferred imports that each led to detectable spread within the country. These results indicate that partial border closure has had little effect on trans-border transmission of variants, which helps explain the rapid global spread of newly arising SARS-CoV-2 variants throughout the pandemic.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esguinces y Distensiones / COVID-19 Tipo de estudio: Screening_studies Límite: Humans País/Región como asunto: Asia / Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esguinces y Distensiones / COVID-19 Tipo de estudio: Screening_studies Límite: Humans País/Región como asunto: Asia / Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Rusia